COMMUNIQUÉS West-GlobeNewswire

-
AroCell AB: announces that a distribution agreement has been signed with Pathway Diagnostics Ltd, for distribution of the AroCell TK 210 ELISA test in United Kingdom and Ireland.
13/10/2017 -
Solon Eiendom ASA : Primary insider notification
13/10/2017 -
Nouveau logo, nouvelle charte, Medasys adopte une nouvelle identité visuelle
13/10/2017 -
Shire plc : New Formulation of ONCASPAR® (pegaspargase) Receives Positive CHMP Opinion in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)
13/10/2017 -
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
13/10/2017 -
Bone Therapeutics SA : The preliminary documents for the Extraordinary General Shareholder Meeting on 30 October 2017 have been made available
13/10/2017 -
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 30 octobre 2017
13/10/2017 -
Medibio completes heavily oversubscribed institutional placement for $13.9 million to accelerate commercialisation
13/10/2017 -
JFR 2017 - Medasys s'associe à Infinitt Healthcare pour répondre aux besoins de partage territoriaux de contenus cliniques et continuer la transformation des métiers en imagerie
12/10/2017 -
ELSALYS BIOTECH acquires from JAZZ PHARMACEUTICALS the worldwide rights of LEUKOTAC®
12/10/2017 -
ELSALYS BIOTECH acquiert auprès de JAZZ PHARMACEUTICALS les droits mondiaux de LEUKOTAC®
12/10/2017 -
Virbac : chiffre d'affaires du troisième trimestre impacté par des effets de déstockage dans la distribution aux Etats-Unis
12/10/2017 -
Virbac: quarterly sales affected by distributor destocking in the United States
12/10/2017 -
Ascom announces a strategic distribution partnership with GE Healthcare in Europe for intensive care units
12/10/2017 -
Terveystalo Oyj - Managers' Transactions
12/10/2017 -
Solon Eiendom ASA : Primary insider notification
12/10/2017 -
Terveystalo Plc: Disclosure under Chapter 9, Section 5 of the Securities Markets Act
12/10/2017 -
Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide
12/10/2017 -
Shire plc : Notice of Results
12/10/2017
Pages